Epidemiologic features of Kawasaki disease in South Korea: Data from nationwide survey, 2009-2011

Pediatric Infectious Disease Journal

Volumn 33, Issue 1, 2014, Pages 24-27

  Kim, Gi Beom ^a   Han, Ji Whan ^b   Park, Yong Won ^c   Song, Min Seob ^c   Hong, Young Mi ^d   Cha, Sung Ho ^e   Kim, Dong Soo ^f   Park, Sohee ^g  

^a Seoul National University Children's Hospital   (South Korea)

^b Uijeongbu St Mary's Hospital   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Ewha Womans University   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Yonsei University   (South Korea)

Author keywords

Epidemiology; Incidence; Kawasaki Disease; Mucocutaneous Lymph Node Syndrome; South Korea

Indexed keywords

IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; STEROID;

ADOLESCENT; ANEURYSM; ARTICLE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; FEMALE; HEALTH SURVEY; HEART INFARCTION; HOSPITAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENCE RISK; RETROSPECTIVE STUDY; SOUTH KOREA; SUMMER; WINTER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; QUESTIONNAIRES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84891561181     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000010     Document Type: Article

References (25)

1. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967;16:178-222
2. Wood LE, Tulloh RM. Kawasaki disease in children. Heart. 2009;95: 787-792
3. N akamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey. J Epidemiol. 2012;22:216-221
4. Park YW, Park IS, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: Comparison with previous studies during 1991-1996. J Korean Med Sci. 2002;17:453-456
5. Park YW, Han JW, Park IS, et al. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002. Pediatr Int. 2005;47:382-387
6. Park YW, Han JW, Park IS, et al. Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J. 2007;26:821-823
7. Park YW, Han JW, Hong YM, et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr Int. 2011;53:36-39
8. R esearch Committee on Kawasaki disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984
9. N ewburger JW, Takahashi M, Gerber MA, et al.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733
10. Huang SK, Lin MT, Chen HC, et al. Epidemiology of Kawasaki disease: Prevalence from national database and future trends projection by system dynamics modeling. J Pediatr. 2013;163:126-131
11. Callinan LS, Tabnak F, Holman RC, et al. Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J. 2012;31:894-898
12. U ehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79-85
13. Huang WC, Huang LM, Chang IS, et al.; Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics. 2009;123:e401-e405
14. Huang GY, Ma XJ, Huang M, et al. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol. 2006;16:9-14
15. N g YM, Sung RY, So LY, et al. Kawasaki disease in Hong Kong, 1994 to 2000. Hong Kong Med J. 2005;11:331-335
16. Holman RC, Belay ED, Curns AT, et al. Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics. 2003;111:448
17. Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: Ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J. 2009;28:21-24
18. Fischer TK, Holman RC, Yorita KL, et al. Kawasaki syndrome in Denmark. Pediatr Infect Dis J. 2007;26:411-415
19. Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364:533-544
20. G helani SJ, Sable C, Wiedermann BL, et al. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol. 2012;33:1097-1103
21. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125:e234-e241
22. D ominguez SR, Anderson MS. AdVances in the treatment of Kawasaki disease. Curr Opin Pediatr. 2013;25:103-109
23. Kobayashi T, Saji T, Otani T, et al.; RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. Lancet. 2012;379:1613-1620
24. Mori M, Imagawa T, Hara R, et al. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: Report of an open-label case series. J Rheumatol. 2012;39:864-867
25. Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008;153:833-838